Scotts Miracle-gro CO 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Scotts Miracle-Gro reported third-quarter results, exceeding expectations and raising its full-year non-GAAP adjusted EPS guidance to $4.30-$4.45.
NYSE
The Scotts Miracle-Gro Company announces a leadership transition with Nate Baxter appointed President & CEO, succeeding long-time leader Jim Hagedorn.
NYSE
Scotts Miracle-Gro announced robust second quarter results with a 5% increase in net sales and significant gross margin improvement, driving EPS growth and reducing net leverage.
NYSE
The Scotts Miracle-Gro Company has completed the sale of its Hawthorne subsidiary to Vireo Growth, Inc. for Vireo shares and warrants, reaffirming its fiscal 2026 guidance.
NYSE
Scotts Miracle-Gro shareholders approved an increase of 2.75 million shares for its long-term incentive plan and re-elected four directors at its annual meeting.
NYSE
Scotts Miracle-Gro reported first-quarter results, announced the divestiture of its Hawthorne subsidiary, and unveiled a new $500 million share repurchase program.
NYSE
The Scotts Miracle-Gro Company has entered into a new $2.0 billion senior secured credit agreement, replacing its previous $2.5 billion facility and extending maturity to November 2030.
NYSE
The Scotts Miracle-Gro Company will begin using a new form of restricted stock unit award notice for its Long-Term Incentive Plan, effective November 13, 2025.
NYSE
The Scotts Miracle-Gro Company reported strong fiscal 2025 full-year results, outperforming expectations for gross margin, EPS, and free cash flow, while providing optimistic fiscal 2026 guidance.
NYSE
The Scotts Miracle-Gro Company extended its $750 million receivables purchase agreement with JPMorgan Chase Bank, N.A. until September 1, 2026, enhancing liquidity for general corporate purposes.
NYSE
The Scotts Miracle-Gro Company announced the retirement of Lt. General John R. Vines from its Board of Directors, replaced by retired General Austin Scott Miller.
NYSE
Scotts Miracle-Gro announced significant improvements in third-quarter financial metrics, including increased gross margin and EPS, while reaffirming its full-year fiscal 2025 guidance.
NYSE
Scotts Miracle-Gro's Q2 2025 results show gross margin improvements driving EBITDA growth, with reaffirmed full-year guidance for the U.S. Consumer segment.
NYSE
Scotts Miracle-Gro reaffirms double-digit POS unit growth for the first half of the fiscal year, as announced by CEO Jim Hagedorn on CNBC's Mad Money.
NYSE
Scotts Miracle-Gro appoints Nick Miaritis to its Board of Directors following the resignation of Tom Kelly.
NYSE
Scotts Miracle-Gro saw a strong start to fiscal 2025 with increased U.S. consumer sales and improved profitability, reaffirming their full-year guidance.
NYSE
Scotts Miracle-Gro's fiscal year 2024 saw a 6 percent increase in U.S. consumer sales and exceeded its free cash flow target, signaling a positive financial turnaround.
NYSE
Scotts Miracle-Gro has appointed Roberto Candelino to its Board of Directors, filling a vacancy and adding his expertise in consumer brands and global markets.
NYSE
Scotts Miracle-Gro has increased its receivables facility to $750 million and extended the termination date to September 1, 2025, providing additional financial flexibility.
NYSE
Scotts Miracle-Gro reported a strong third quarter with U.S. consumer sales up 11% and significant improvements in profitability.
NYSE
Scotts Miracle-Gro's second quarter results show strong performance in the U.S. Consumer segment and significant improvements in gross margin, putting the company on track to meet its full-year targets.
NYSE
Scotts Miracle-Gro anticipates a net leverage ratio around 7 times adjusted EBITDA for the second quarter, an improvement from the first quarter and below the maximum allowed, driven by strong retail shipments and positive free cash flow.
NYSE
Scotts Miracle-Gro has approved a new performance unit award agreement under its Long-Term Incentive Plan for certain employees, including named executive officers.
NYSE
Scotts Miracle-Gro reported a first-quarter loss but reaffirmed its full-year guidance for adjusted gross margin improvement and adjusted EBITDA.
NYSE
Nancy Mistretta has retired from the Scotts Miracle-Gro Board of Directors, prompting a search for a replacement and a continued board refresh.
NYSE
Scotts Miracle-Gro shareholders approved an amendment to the company's long-term incentive plan, increasing the number of shares available for grants, and elected four directors at their annual meeting.